Alexion Pharma (ALXN) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts ALXN Hot Sheet
Price: $182.01 --0%
Financial Fact:
Investment income: 1.87M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Investment income: 1.87M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Alexion Pharma (NASDAQ: ALXN) reported Q1 EPS of $1.11, $0.02 worse than the analyst estimate of $1.13. Revenue for the quarter came in at $701 million versus the consensus estimate of $710.98 million.
For earnings history and earnings-related data on Alexion Pharma (ALXN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Terra Innovatum Global N.V. (NKLR) Misses Q2 EPS by 12c
- Prenetics Global (PRE) Tops Q2 EPS by 18c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
